2 Summary Statistics

Data Notes:
  • Mpox was previously known as monkeypox.
  • Primary, secondary & early non-primary non-secondary syphilis conditions are early-stage or recent infections.

    • 2.1 Top 20 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 18,246 145,878 141,302 116,907 0
    Chlamydia trachomatis infection 5,587 5,752 5,818 5,393 5,704
    Gonorrhea 1,769 1,986 2,327 1,946 1,877
    Tuberculosis, Latent Infection (LTBI) 863 688 487 367 564
    Hepatitis C virus infection, chronic 535 661 846 496 693
    Influenza-associated hospitalization 524 934 49 481 786
    RSV 368 154 635 424 538
    Syphilis (primary, secondary, early latent) 357 296 213 136 171
    Cryptosporidiosis 305 73 35 40 67
    Campylobacteriosis 267 209 176 131 197
    Salmonellosis 236 143 119 110 140
    Streptococcal disease, invasive, Group A 184 156 136 115 137
    Giardiasis 116 83 85 63 99
    Streptococcal disease, invasive, Group B 105 108 106 103 116
    Shigellosis 104 39 31 30 46
    Streptococcus pneumoniae, invasive disease 101 110 91 75 118
    Shiga toxin-producing Escherichia coli (STEC) 99 89 72 61 72
    Hepatitis C, acute 90 118 130 55 76
    Hepatitis B virus infection, chronic 84 55 59 62 106
    Pertussis 77 93 62 61 238

    2.2 Age <1 year: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 941 2,132 1,030 421 0
    Influenza-associated hospitalization 17 35 <5 17 30
    Salmonellosis 9 8 7 <5 7
    Syphilis, congenital 6 <5 <5 <5 <5
    Streptococcal disease, invasive, Group B 5 8 14 10 9
    Pertussis <5 <5 <5 <5 10
    Streptococcal disease, invasive, Group A <5 <5 <5 <5 <5
    Cryptosporidiosis <5 <5 <5 <5 <5
    Campylobacteriosis <5 5 <5 <5 <5
    Influenza-associated death in a person under 18 <5 <5 <5 <5 <5

    2.3 Age 1-4 years: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 523 4,215 3,831 1,521 0
    Influenza-associated hospitalization 46 61 <5 39 54
    Cryptosporidiosis 42 5 <5 <5 <5
    Salmonellosis 14 8 <5 7 7
    Shigellosis 13 <5 <5 <5 <5
    Campylobacteriosis 12 9 9 10 12
    Pertussis 11 <5 <5 6 38
    Chickenpox (Varicella) 9 5 5 <5 13
    Giardiasis 7 12 <5 <5 10
    Shiga toxin-producing Escherichia coli (STEC) 6 8 9 <5 16

    2.4 Age 5-17 years: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 1,139 19,593 24,273 16,028 0
    Chlamydia trachomatis infection 331 392 405 425 453
    Cryptosporidiosis 77 5 <5 5 5
    Influenza-associated hospitalization 71 98 5 31 60
    Tuberculosis, Latent Infection (LTBI) 59 30 25 15 28
    Gonorrhea 46 53 72 66 54
    Chickenpox (Varicella) 32 <5 10 19 25
    Campylobacteriosis 24 14 20 14 19
    Salmonellosis 23 21 13 12 12
    Shiga toxin-producing Escherichia coli (STEC) 17 13 14 13 16

    2.5 Age 18-29 years: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Chlamydia trachomatis infection 3,596 3,785 3,817 3,598 3,838
    Coronavirus, Novel (2019-nCoV) 3,017 34,611 35,022 31,820 0
    Gonorrhea 800 991 1,061 997 946
    Tuberculosis, Latent Infection (LTBI) 163 143 91 76 136
    Syphilis (primary, secondary, early latent) 119 94 62 47 59
    Hepatitis C virus infection, chronic 99 97 139 78 124
    Syphilis, unknown duration or late 76 36 38 30 27
    Salmonellosis 37 23 18 24 25
    Campylobacteriosis 36 42 31 21 40
    Cryptosporidiosis 32 13 7 13 16

    2.6 Age 30-49 years: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 5,025 48,301 48,651 40,076 0
    Chlamydia trachomatis infection 1,510 1,433 1,453 1,240 1,288
    Gonorrhea 792 819 1,005 773 756
    Tuberculosis, Latent Infection (LTBI) 370 293 217 170 235
    Hepatitis C virus infection, chronic 254 347 473 231 302
    Syphilis (primary, secondary, early latent) 183 163 121 64 81
    Cryptosporidiosis 106 26 14 9 18
    Influenza-associated hospitalization 98 133 10 85 117
    Syphilis, unknown duration or late 96 76 38 30 47
    Campylobacteriosis 89 68 55 34 57

    2.7 Age 50-64 years: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 3,300 22,002 18,958 18,311 0
    Tuberculosis, Latent Infection (LTBI) 182 145 98 76 116
    Chlamydia trachomatis infection 131 133 133 126 112
    Hepatitis C virus infection, chronic 124 162 174 148 193
    Gonorrhea 116 116 179 103 111
    Influenza-associated hospitalization 97 178 10 122 170
    Campylobacteriosis 51 41 31 25 37
    Streptococcal disease, invasive, Group A 48 43 46 32 42
    Syphilis (primary, secondary, early latent) 43 38 26 20 26
    Salmonellosis 40 28 25 16 28

    2.8 Age 65+ years: Top 10 Reportable Diseases

    Disease 2023 2022 2021 2020 2019
    Coronavirus, Novel (2019-nCoV) 4,298 15,019 9,531 8,721 0
    Influenza-associated hospitalization 166 347 13 157 318
    Tuberculosis, Latent Infection (LTBI) 87 65 56 27 47
    Streptococcal disease, invasive, Group A 65 64 48 44 43
    Hepatitis C virus infection, chronic 56 53 56 36 68
    Campylobacteriosis 53 30 26 26 28
    Streptococcal disease, invasive, Group B 43 34 31 34 41
    Streptococcus pneumoniae, invasive disease 37 29 23 20 27
    Salmonellosis 33 16 13 16 18
    Enterobacter species - Carbapenem resistant 29 39 30 31 24